Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Vanquis Banking H1 losses widen amid transformation efforts

(Sharecast News) - Sub-prime lender Vanquis Banking said on Thursday that interim losses had widened even as it made "good progress" on its transformation efforts. Vanquis said adjusted pre-tax losses had widened from £21.9m to £46.5m in the six months ended 30 June, while total income fell 1.3% to £234.0m.

Operating costs rose 7.9% to £179.2m, with impairment charges up 8.9% to £101.3m, while net interest margins were stable at 18.8%.

Chief executive Ian McLaughlin said: "We are making good progress on our business transformation and refreshed customer proposition presented in March. New customer volumes grew in the first half at better margins, leading to overall receivables growth in June.

"As the largest specialist finance provider for financially underserved customers, Vanquis occupies a unique role in the UK banking system. We look forward to continuing to support our customers to make the most of life's opportunities."

As of 0930 BST, Vanquis shares were up 4.56% at 57.30p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

UK watchdog to probe Google, Apple over mobile ecosystems
(Sharecast News) - The UK competition watchdog has launched an investigation into Google and Apple's dominance across smartphone ecosystems, it confirmed on Thursday.
JPMorgan cuts Inchcape to 'neutral', places on 'negative catalyst watch'
(Sharecast News) - Inchcape tumbled on Thursday as JPMorgan Cazenove downgrades shares of the car dealership to 'neutral' from 'overweight' and slashed the price target to 800p from 1,050p.
Shore Capital sees major upside at Spectris if targets are hit
(Sharecast News) - Shore Capital has reiterated its 'buy' rating for Spectris after an encouraging update from the precision instruments group on Thursday, saying it sees the potential for a material ratings upgrade.
Berenberg slashes target price on Angle
(Sharecast News) - Analysts at Berenberg slashed their target price on liquid biopsy specialist Angle from 70.0p to 40.0p on Thursday but said the group was "repositioned for growth" in FY25.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.